Reintroducing finasteride after your previous experiences requires a cautious and well-considered approach, especially given your significant neuropsychiatric reactions in the past. It appears that the initial reaction may have been influenced by temporary CNS sensitization due to the severe cannabis-induced event, which could have amplified your response to finasteride. However, it’s also possible that there is an underlying intolerance to finasteride itself that was exacerbated during a time of increased nervous system vulnerability.
Given the passage of time and achieving a stable baseline, reintroducing finasteride—should you choose to—demands careful consideration. Topical finasteride or ultra-low-dose oral finasteride are potential options to lower systemic exposure and possibly minimize side effects. Starting with a topical form may be reasonable, as systemic absorption is typically lower, hence reducing systemic effects, but individual variability exists.
Before re-exposure, a formal consultation with a dermatologist or endocrinologist experienced in managing finasteride is essential. They can guide you through potential options and monitor your response closely. A psychiatrist or neuropsychiatrist input could also be valuable, considering your neuropsychiatric history. While specific lab markers for finasteride sensitivity aren’t established, general health markers (like vitamin D levels and overall hormonal profile) can be checked to ensure your body is in a good baseline state.
Monitoring your mental and physical reactions closely following any re-exposure will be crucial. Document any changes meticulously, so these can be discussed with your healthcare provider. Be prepared to halt the medication if any of the adverse symptoms return. Ultimately, while a potential re-test can be cautiously attempted, be mindful that complete avoidance remains an option, particularly if any significant concerns arise during or after re-exposure.
